Adlib and Pfizer to Provide Webinar on Streamlining Regulatory Submissions to Avoid Rejections

BURLINGTON, ONTARIO, CANADA--(BUSINESS WIRE)--Adlib, the leading expert in Enterprise Content Transformation, today announced a complimentary live webinar titled “Pfizer Streamlines Pharma Submissions” on August 9, 2011, at 11:00 a.m. Eastern. Attendees will learn how Pfizer shortens submission times, improves inefficiencies and reduces time-consuming and error-prone PDF transformation problems. The Adlib Platform provides enterprise-grade, best-of-breed content-to-PDF transformation capabilities for document-intensive and highly regulated industries.

The requirements for Electronic Common Technical Document (eCTD)-compliant submissions are unique and must be applied to documents that are constantly evolving. As an Investigational New Drug Application (IND) or New Drug Application (NDA) submission is prepared, the incorporated documents are continuously under review, endlessly annotated and changing through internal and external improvements. This increases the risk of corrupting the submission, creating errors in post-production re-rendering. The revenue window for pharmaceutical companies is directly linked to the patent clock, so the speed of submission processing can add millions of dollars to a company’s bottom line.

Using an Enterprise Content Transformation solution, Pfizer is able to meet stringent government agency standards and drastically increase efficiency in the submission process while optimizing its revenue window of opportunity. In this webinar, representatives from Adlib and Pfizer will explain how Adlib’s Enterprise Content Transformation platform easily delivers submission-ready PDF renditions through an optimized regulatory submission process, resulting in increased revenue and improved speed-to-market. In addition to Pfizer, Adlib also saves millions of dollars in the submission process for leading pharmaceutical companies such as Bayer, Coley, Eli Lilly, Genentech and OSI.


What: Webinar titled “Pfizer Streamlines Pharma Submissions”

When: August 9, 2011 at 11:00 a.m. Eastern

To register please click here: Adlib and Pfizer to Provide Webinar on Streamlining Regulatory Submissions to Avoid Rejections